Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)
1 clinical trials · Condition
◉ Watch Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML)
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML) (NCT05100303) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2021-12-01 |
Track Treatment-naive or Relapsed or Refractory Acute Myeloid Leukemia (AML) automatically
Every clearance here is in the API, with alerts when new ones post.